Leveraging in-depth analyst evaluations, we have distilled key insights from expert assessments to provide a compelling outlook for HIVE. Our analysts point to weakening fundamentals and unfavorable market sentiment, indicating considerable downside risk in the near term. Based on this in-depth expert analysis, we hold a highly cautious view of this stock. Our conclusion: HIVE is a Strong Sell candidate.
HIVE price ended at $0.072650 on 星期五, after rising 0.35%
On Feb 13, 2026 00:00, the price of HIVE rose by 0.35%, climbing from $0.070981 to $0.072650 with 24h trading volume reaching $2.3M HIVE.
